# Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia

> **NCT03838484** · NA · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 18 (actual)

## Conditions studied

- Schizophrenia
- Impulsive Behavior

## Interventions

- **DRUG:** Nicotine Patch, 7 Mg/24 Hr
- **DRUG:** Placebo patch

## Key facts

- **NCT ID:** NCT03838484
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-10
- **Primary completion:** 2020-02-24
- **Final completion:** 2020-02-24
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Recruitment challenges due to Covid19.
- **Last updated:** 2022-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03838484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03838484, "Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03838484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*